US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CytoDyn Inc.

0.2586

-0.0074-2.78%

Volume:3.63M

Turnover:954.53K

Market Cap:324.19M

PE:-7.98

High:0.2708

Open:0.2700

Low:0.2537

Close:0.2660

52wk High:0.4470

52wk Low:0.1925

Shares:1.25B

Float Shares:1.25B

Volume Ratio:1.67

T/O Rate:0.29%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0324

EPS(LYR):-0.2868

ROE:1659.17%

ROA:-70.67%

PB:-2.71

PE(LYR):-0.90

Loading ...

Overview Company News Filings

Company Profile

Company Name:

CytoDyn Inc.

Exchange:

OTCQB

Establishment Date:

2002

Employees:

13

Office Location:

1111 Main Street,Suite 660,Vancouver,Washington,United States

Website:

http://www.cytodyn.com

Zip Code:

98660

Phone:

Fax:

360 799 5954

Introduction:

CytoDyn Inc., a clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications. The company is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19, human immunodeficiency virus (HIV), Metabolic dysfunction-associated steatohepatitis (MASH), and solid tumors in oncology, such as metastatic triple-negative breast cancer. Its leronlimab is currently under phase 2 development for the treatment of NASH, HIV- NASH, and solid tumors, as well as under pre-clinical development for the treatment of HIV-PrEP and HIV-Cure. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CYDY/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CYDY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CYDY\",,,,,undefined,":{"symbol":"CYDY","market":"US","secType":"STK","nameCN":"CytoDyn Inc.","latestPrice":0.2586,"timestamp":1771966800000,"preClose":0.266,"halted":0,"volume":3631197,"delay":15,"changeRate":-0.027819548872180515,"floatShares":1252865057,"shares":1253645452,"eps":-0.032401,"marketStatus":"Closed","change":-0.0074,"latestTime":"02-24 16:00:00 EST Delay","open":0.27,"high":0.2708,"low":0.2537,"amount":954529.048429,"amplitude":0.064286,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.032401,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1772010000000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.266,"volumeRatio":1.668959},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CYDY\",,,,,undefined,":{"symbol":"CYDY","floatShares":1252865057,"roa":"-70.67%","roe":"1659.17%","lyrEps":-0.286757,"volumeRatio":1.668959,"shares":1253645452,"dividePrice":0,"high":0.2708,"amplitude":0.064286,"preClose":0.266,"low":0.2537,"week52Low":0.1925,"pbRate":"-2.71","week52High":0.447,"institutionHeld":0,"latestPrice":0.2586,"eps":-0.032401,"divideRate":0,"volume":3631197,"delay":15,"ttmEps":-0.032401,"open":0.27,"prevYearClose":0.28,"prevWeekClose":0.2593,"prevMonthClose":0.2444,"prevQuarterClose":0.28,"fiveDayClose":0.243,"twentyDayClose":0.2511,"sixtyDayClose":0.345},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CYDY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-01-14","symbol":"CYDY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1736830800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-10-15","symbol":"CYDY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1728964800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-08-15","symbol":"CYDY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723694400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-04-15","symbol":"CYDY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1713153600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-01-16","symbol":"CYDY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1705381200000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CYDY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CYDY\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":10039157,"yearFounded":2002,"employeeNum":13,"address":"1111 Main Street,Suite 660,Vancouver,Washington,United States","zipCode":"98660","officePhone":"360 980 8524","officeFax":"360 799 5954"},"stockCompanyDetail":{"websiteUrl":"http://www.cytodyn.com","stockEarnings":[{"period":"1week","weight":-0.0877},{"period":"1month","weight":-0.1015},{"period":"3month","weight":-0.2113},{"period":"6month","weight":-0.2113},{"period":"1year","weight":-0.3469},{"period":"ytd","weight":-0.2449}],"description":"CytoDyn Inc., a clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications. The company is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19, human immunodeficiency virus (HIV), Metabolic dysfunction-associated steatohepatitis (MASH), and solid tumors in oncology, such as metastatic triple-negative breast cancer. Its leronlimab is currently under phase 2 development for the treatment of NASH, HIV- NASH, and solid tumors, as well as under pre-clinical development for the treatment of HIV-PrEP and HIV-Cure. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.","exchange":"OTCQB","name":"CytoDyn Inc.","nameEN":"CytoDyn Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CYDY\",market:\"US\",,,undefined,":null}}